Cargando…
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference
IMPORTANCE: Cell-free DNA (cfDNA) testing is increasingly used in the treatment of patients with advanced prostate cancer. Clonal hematopoiesis of indeterminate potential (CHIP) can interfere with cfDNA testing and cause incorrect interpretation of results. There is an urgent need to better understa...
Autores principales: | Jensen, Kendal, Konnick, Eric Q., Schweizer, Michael T., Sokolova, Alexandra O., Grivas, Petros, Cheng, Heather H., Klemfuss, Nola M., Beightol, Mallory, Yu, Evan Y., Nelson, Peter S., Montgomery, Bruce, Pritchard, Colin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645740/ https://www.ncbi.nlm.nih.gov/pubmed/33151258 http://dx.doi.org/10.1001/jamaoncol.2020.5161 |
Ejemplares similares
-
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
por: Schweizer, Michael T., et al.
Publicado: (2016) -
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
por: Hempelmann, Jennifer A., et al.
Publicado: (2018) -
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer
por: Cheng, Heather H., et al.
Publicado: (2023) -
Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations
por: Kuo, Ayako J., et al.
Publicado: (2020) -
Chipping in on clonal hematopoiesis
por: Gillis, Nancy K., et al.
Publicado: (2017)